Bioceres Crop Solutions Corp. (BIOX)

Bioceres Crop Solutions Statistics

Total Valuation

BIOX has a market cap or net worth of $98.00 million. The enterprise value is $338.01 million.

Market Cap	98.00M
Enterprise Value	338.01M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BIOX has 63.23 million shares outstanding. The number of shares has decreased by -0.17% in one year.

Current Share Class	63.23M
Shares Outstanding	63.23M
Shares Change (YoY)	-0.17%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	1.31%
Owned by Institutions (%)	15.27%
Float	32.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.30
Forward PS	0.38
PB Ratio	0.37
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.06
EV / EBITDA	30.33
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.90.

Current Ratio	0.91
Quick Ratio	0.62
Debt / Equity	0.90
Debt / EBITDA	15.98
Debt / FCF	n/a
Interest Coverage	-0.18

Financial Efficiency

Return on equity (ROE) is -18.96% and return on invested capital (ROIC) is -0.55%.

Return on Equity (ROE)	-18.96%
Return on Assets (ROA)	-0.40%
Return on Invested Capital (ROIC)	-0.55%
Return on Capital Employed (ROCE)	-1.20%
Revenue Per Employee	$423,494
Profits Per Employee	-$75,121
Employee Count	751
Asset Turnover	0.41
Inventory Turnover	1.85

Taxes

In the past 12 months, BIOX has paid $4.67 million in taxes.

Income Tax	4.67M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.96% in the last 52 weeks. The beta is 0.44, so BIOX's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-74.96%
50-Day Moving Average	1.67
200-Day Moving Average	3.51
Relative Strength Index (RSI)	44.15
Average Volume (20 Days)	639,352

Short Selling Information

Short Interest	926,526
Short Previous Month	679,792
Short % of Shares Out	1.47%
Short % of Float	2.83%
Short Ratio (days to cover)	0.68

Income Statement

In the last 12 months, BIOX had revenue of $318.04 million and -$56.42 million in losses. Loss per share was -$0.89.

Revenue	318.04M
Gross Profit	125.16M
Operating Income	-5.06M
Pretax Income	-55.47M
Net Income	-56.42M
EBITDA	11.14M
EBIT	-5.06M
Loss Per Share	-$0.89

Balance Sheet

The company has $16.60 million in cash and $258.50 million in debt, giving a net cash position of -$241.90 million or -$3.83 per share.

Cash & Cash Equivalents	16.60M
Total Debt	258.50M
Net Cash	-241.90M
Net Cash Per Share	-$3.83
Equity (Book Value)	288.30M
Book Value Per Share	4.08
Working Capital	-28.20M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 39.35%, with operating and profit margins of -1.59% and -17.74%.

Gross Margin	39.35%
Operating Margin	-1.59%
Pretax Margin	-17.44%
Profit Margin	-17.74%
EBITDA Margin	3.50%
EBIT Margin	-1.59%
FCF Margin	n/a

Dividends & Yields

BIOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.17%
Shareholder Yield	0.17%
Earnings Yield	-58.70%
FCF Yield	n/a

Analyst Forecast

The average price target for BIOX is $4.42, which is 185.16% higher than the current price. The consensus rating is "Buy".

Price Target	$4.42
Price Target Difference	185.16%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1